<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0000867'>Secondary hyperparathyroidism</z:hpo> is a common complication of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">kidney disease</z:e> and it is associated with high morbidity and mortality </plain></SENT>
<SENT sid="1" pm="."><plain>It is characterized by high parathyroid hormone levels and bone turnover leading to <z:hpo ids='HP_0002653'>bone pain</z:hpo>, deformity and fragility </plain></SENT>
<SENT sid="2" pm="."><plain>Furthermore, <z:hpo ids='HP_0000867'>secondary hyperparathyroidism</z:hpo> adversely affects the cardiovascular system and has been associated with <z:hpo ids='HP_0011915'>cardiovascular calcification</z:hpo> and <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="48390">Cinacalcet</z:chebi>, a type II <z:chebi fb="0" ids="48525">calcimimetic</z:chebi>, is an effective and well-tolerated oral therapy for the management of <z:hpo ids='HP_0000867'>secondary hyperparathyroidism</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>It is an allosteric activator of the calcium-sensing receptor enhancing sensitivity of parathyroid cells to extracellular calcium, which leads to inhibition of parathyroid hormone secretion </plain></SENT>
<SENT sid="5" pm="."><plain>The calcium-sensing receptor expression in cardiomyocytes, endothelial cells and vascular smooth muscle cells raises the possibility that this receptor may be implicated in the pathophysiology of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> and constitute a potential therapeutic target </plain></SENT>
<SENT sid="6" pm="."><plain>This article reviews the role of the <z:chebi fb="0" ids="48525">calcimimetic</z:chebi> agent <z:chebi fb="0" ids="48390">cinacalcet</z:chebi> in the prevention and progression of <z:hpo ids='HP_0011915'>cardiovascular calcification</z:hpo> and uremic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> in the <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">kidney disease</z:e> setting </plain></SENT>
</text></document>